Cystic Fibrosis: Understanding Its Genetic Roots

Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in the CFTR gene (Cystic Fibrosis Transmembrane Conductance Regulator) on chromosome 7. The CFTR protein functions as a chloride channel; its dysfunction leads to thick, sticky mucus in lungs, pancreas, and other organs.

Inheritance Pattern

  • A child must inherit two mutated CFTR alleles (one from each parent) to have CF.
  • Parents are typically asymptomatic carriers (heterozygous).
  • Carrier frequency: ~1 in 25 Caucasians, 1 in 65 African Americans, 1 in 46 Hispanics, 1 in 90 Asians.
  • If both parents are carriers: 25% chance of affected child per pregnancy; 50% carrier; 25% unaffected non-carrier.

Common Mutations

  • F508del (ΔF508): Most common (~70% of CF alleles worldwide). Causes protein misfolding and degradation.
  • Over 2,000 known variants; classified by functional consequence (Classes I–VI) guiding modulator therapy eligibility.

Clinical Implications

  • Newborn Screening: Universal in US (IRT/DNA panel). Early diagnosis → early intervention → improved survival.
  • Carrier Screening: Recommended for all pregnant women or those planning pregnancy (ACOG/ACMG).
  • CFTR Modulator Therapies: Trikafta (elexacaftor/tezacaftor/ivacaftor) corrects F508del defect—transformative for ~90% of patients.
  • Genetic Counseling: Essential for carriers, affected individuals, and families for reproductive planning.

Resources

CF is a multisystem disease, but advances in genetics and targeted therapy have dramatically improved life expectancy (now >50 years median). Early diagnosis and specialized care are critical.

Genetic Disorders - Related Articles